Vaccination

	B.C.G. Polio ( Polio) – zero polio Hepatitis B – first
1.5 months	D.P.T. – 1st dose Polio ( 1st dose Hepatitis–B– 2nd HIB Meningitis – Brain Fever – 1st  dose
2.5 months	DPT – 2nd  dose Polio -  2nddose HIB Meningitis – 2nd dose
3.5 months	DPT – 3rd dose Polio – 3rd  dose HIB Meningitis – 3rd  dose
6 months	Hepatitis-B – 3rd dose
9 months	Measles Polio – 5th dose
15 months	M M R
1 year	Chickenpox
1.5 years	DPT Booster Polio – Booster HIB Meningitis – Booster dose
2 years	Typhoid Hepatitis A

Vaccine	Manufacturer	BLA submitted to FDA	BLA age indications**	FDA licensure	Status of AAP/CDC recommendations***
DTaP/IPV (KINRIX)	GlaxoSmithKline (GSK)	Jun-2007	4 through 6 years of age	Licensed 24-Jun-08	AAP: aapnews.aappublications.org/cgi/content/full/29/8/20 CDC: cdc.gov/mmwr/preview/mmwrhtml/mm5739a4.htm
Hib/DTaP/IPV (PENTACEL™)	sanofi pasteur	Jul-2005	2, 4, 6, and 15 to 18 months of age	Licensed 20-Jun-08	AAP: aapnews.aappublications.org/cgi/content/full/29/8/1-b CDC: cdc.gov/mmwr/preview/mmwrhtml/mm5739a5.htm
Hib(Hiberix)	GlaxoSmithKline (GSK)	Mar-2009	Booster dose in children 15 months through 4 years of age	Licensed 19-Aug-09	CDC: cdc.gov/mmwr/preview/mmwrhtml/mm5836a5.htm
Hepatitis A (VAQTA®)	Merck	Supplement to original BLA	Greater than or equal to 12 months of age	Licensed 11-Aug-05	AAP: aappolicy.aappublications.org/cgi/content/full/pediatrics;120/1/189 CDC: cdc.gov/mmwr/preview/mmwrhtml/rr5507a1.htm CDC for post-exposure and for international travelers cdc.gov/mmwr/preview/mmwrhtml/mm5641a3.htm
Hepatitis A (HAVRIX®)	GlaxoSmithKline (GSK)	Supplement to original BLA	Greater than or equal to 12 months of age	Licensed 17-Oct-05
Hepatitis A and Hepatitis B (TWINRIX®)	GlaxoSmithKline (GSK)	Supplement to original BLA: accelerated dosing	Greater than or equal to 18 years of age 0, 7, and 21 through 30 days and 12 month booster	Licensed 28-Mar-07	CDC: cdc.gov/mmwr/preview/mmwrhtml/mm5640a5.htm
Herpes zoster vaccine (ZOSTAVAX®)	Merck	Apr-2005	Greater than or equal to 60 years of age	Licensed 25-May-06	ACIP: cdc.gov/mmwr/preview/mmwrhtml/rr57e0515a1.htm
HPV (GARDASIL®)	Merck	Dec-2005	9 through 26 years of age (3 doses)	Licensed 8-Jun-06	ACIP: cdc.gov/mmwr/preview/mmwrhtml/rr56e312a1.htm AAP: aappolicy.aappublications.org/cgi/content/full/pediatrics;120/3/666
		Supplement to original BLA	27 through 45 years of age	To be reviewed	Pending FDA licensure
HPV (Cervarix™)	GlaxoSmithKline (GSK)	Mar-2007	Data not available	To be reviewed	Pending FDA licensure
Influenza vaccines - TIV	varies	n/a	See recommendations	varies	AAP: aappolicy.aappublications.org/cgi/content/full/pediatrics;124/4/1216 CDC: cdc.gov/mmwr/preview/mmwrhtml/rr5808a1.htm H1N1: cdc.gov/mmwr/preview/mmwrhtml/rr58e0821a1.htm
Influenza - LAIV-T (FluMist®)	MedImmune	Supplement to original BLA	24 months to 49 years of age	Licensed 19-Sep-07
Japanese Encephalitis (IXIARO)	Intercell Biomedical	Dec-2007	Greater than or equal to 17 years of age	Licensed 30-Mar-09	ACIP Provisional: cdc.gov/vaccines/recs/provisional/downloads/je-july2009-508.pdf
MCV4 (Menactra®)	sanofi pasteur	Dec-2003	11 through 55 years of age	Licensed 14-Jan-05	AAP: aappolicy.aappublications.org/cgi/content/full/pediatrics;116/2/496 CDC: cdc.gov/mmwr/preview/mmwrhtml/rr5407a1.htm
		Supplement to original BLA March 2005	2 through 10 years of age only for children at high risk	Licensed 18-Oct-07	ACIP: cdc.gov/mmwr/preview/mmwrhtml/mm5717a4.htm
MCV4 (Menveo™)	Novartis	Aug-2008	11 through 55 years of age	To be reviewed	Pending FDA licensure
MMRV (ProQuad®)	Merck	Aug-2004	Same as for MMR dose 1 or dose 2; 12 months to 12 years of age	Licensed 6-Sep-05	CDC: cdc.gov/mmwr/preview/mmwrhtml/mm5447a4.htm CDC Update: cdc.gov/mmwr/preview/mmwrhtml/mm5710a3.htm
PCV13 (Prevnar 13®)	Wyeth	Mar-2009	2 months to 5 years of age	To be reviewed	Pending FDA licensure
Rotavirus (ROTATEQ®)	Merck	Apr-2005	2, 4, and 6 months of age	Licensed 3-Feb-06	AAP: aappolicy.aappublications.org/cgi/content/full/pediatrics;123/5/1412 ACIP: cdc.gov/mmwr/PDF/rr/rr5802.pdf
Rotavirus (ROTARIX®)	GlaxoSmithKline (GSK)	Jun-2007	2 and 4 months of age	Licensed 3-Apr-08
Tdap (BOOSTRIX®)	GlaxoSmithKline (GSK)	Jul-2004	10 through 18 years of age	Licensed 3-May-05	AAP: aappolicy.aappublications.org/cgi/content/full/pediatrics;117/3/965 CDC: cdc.gov/mmwr/preview/mmwrhtml/rr5503a1.htm
		Supplement to original BLA	19 through 64 years of age	Licensed 4-Dec-08	CDC: cdc.gov/mmwr/preview/mmwrhtml/mm5814a5.htm
Tdap (ADACEL™)	sanofi pasteur	Aug-2004	11 through 64 years of age	Licensed 10-Jun-05	AAP: aappolicy.aappublications.org/cgi/content/full/pediatrics;117/3/965 CDC Adolescent: cdc.gov/mmwr/preview/mmwrhtml/rr5503a1.htm CDC Adult: cdc.gov/mmwr/preview/mmwrhtml/rr5517a1.htm ACIP in Pregnancy: cdc.gov/mmwr/preview/mmwrhtml/rr5704a1.htm
Varicella virus second dose (Varivax®)	Merck	Supplement to original BLA: second dose	12 months to 12 years of age (3 month minimum interval)	Licensed 5-Apr-05	AAP: aappolicy.aappublications.org/cgi/content/full/pediatrics;120/1/221 CDC: cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm